Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.055
+0.093 (9.63%)
At close: May 1, 2026, 4:00 PM EDT
1.070
+0.015 (1.42%)
After-hours: May 1, 2026, 7:49 PM EDT
Sunshine Biopharma Revenue
In the year 2025, Sunshine Biopharma had annual revenue of $36.31M with 4.11% growth. Sunshine Biopharma had revenue of $8.58M in the quarter ending December 31, 2025, a decrease of -10.61%.
Revenue (ttm)
$36.31M
Revenue Growth
+4.11%
P/S Ratio
0.14
Revenue / Employee
$726,118
Employees
50
Market Cap
5.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 36.31M | 1.43M | 4.11% |
| Dec 31, 2024 | 34.87M | 10.78M | 44.75% |
| Dec 31, 2023 | 24.09M | 19.75M | 454.42% |
| Dec 31, 2022 | 4.35M | 4.12M | 1,802.41% |
| Dec 31, 2021 | 228.43K | 157.02K | 219.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biofrontera | 41.71M |
| IM Cannabis | 39.92M |
| cbdMD | 19.09M |
| Universe Pharmaceuticals INC | 17.86M |
| Sonoma Pharmaceuticals | 17.72M |
| InMed Pharmaceuticals | 4.51M |
| China SXT Pharmaceuticals | 1.54M |
| RedHill Biopharma | 286.00K |
SBFM News
- 27 days ago - Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year - Accesswire
- 6 months ago - Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM) - Accesswire
- 6 months ago - Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea - Accesswire
- 6 months ago - Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline - Accesswire
- 7 months ago - Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin - Accesswire
- 7 months ago - Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM) - Accesswire
- 7 months ago - Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM) - Accesswire
- 7 months ago - Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience - Accesswire